Literature DB >> 26547586

Increased expression of ESCO1 is correlated with poor patient survival and its role in human bladder cancer.

Shiying Zhang1, Jianye Li1, Gaobiao Zhou1, Dawei Mu1, Jingmin Yan1, Jizhang Xing1, Zhiyong Yao1, Haibo Sheng1, Di Li1, Chao Lv1, Bin Sun1, Quan Hong1, Heqing Guo2.   

Abstract

There is increasing evidence suggesting that establishment of sister chromatid cohesion N-acetyltransferase 1 (ESCO1) was involved in tumorigenesis. However, its role in bladder cancer remains unclear. In this study, we aimed to study the clinical correlation and biological significance of ESCO1 in bladder cancer. Our results showed that ESCO1 was significantly over-expressed in bladder cancer tissues compared with that in adjacent normal tissues. And, increased ESCO1 expression was significantly associated with higher grade (P < 0.001), higher tumor stage (P = 0.014), and multifocality (P = 0.042). Kaplan-Meier analysis and Cox proportional hazards model were performed to determine the prognostic significance of ESCO1, and the results showed that ESCO1 is a useful prognostic marker for bladder cancer patients. Moreover, we found that ESCO1 knockdown inhibited the growth, migration, and invasion of bladder cancer cells. In conclusion, our findings indicated that ESCO1 may play an important role in human bladder cancer, and ESCO1 might serve as a novel target and prognosis factor for human bladder cancer.

Entities:  

Keywords:  Bladder cancer; Carcinogenesis; Chromosome instability gene; ESCO1; Prognostic factor

Mesh:

Substances:

Year:  2015        PMID: 26547586     DOI: 10.1007/s13277-015-4375-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  20 in total

1.  Alteration of cohesin genes in myeloid diseases.

Authors:  Julien Rocquain; Véronique Gelsi-Boyer; José Adélaïde; Anne Murati; Nadine Carbuccia; Norbert Vey; Daniel Birnbaum; Marie-Joelle Mozziconacci; Max Chaffanet
Journal:  Am J Hematol       Date:  2010-09       Impact factor: 10.047

Review 2.  Defining optimal therapy for muscle invasive bladder cancer.

Authors:  Harry W Herr; Zohar Dotan; S Machele Donat; Dean F Bajorin
Journal:  J Urol       Date:  2007-02       Impact factor: 7.450

3.  Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers.

Authors:  Thomas D Barber; Kirk McManus; Karen W Y Yuen; Marcelo Reis; Giovanni Parmigiani; Dong Shen; Irene Barrett; Yasaman Nouhi; Forrest Spencer; Sanford Markowitz; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christoph Lengauer; Philip Hieter
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

4.  Predisposition for TMPRSS2-ERG fusion in prostate cancer by variants in DNA repair genes.

Authors:  Manuel Luedeke; Carmen M Linnert; Matthias D Hofer; Harald M Surowy; Antje E Rinckleb; Josef Hoegel; Rainer Kuefer; Mark A Rubin; Walther Vogel; Christiane Maier
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-27       Impact factor: 4.254

5.  Prognostic significance of Aurora-A expression in human bladder cancer.

Authors:  Yu Lei; Sun Yan; Lei Ming-De; Li Na; Han Rui-Fa
Journal:  Acta Histochem       Date:  2010-07-02       Impact factor: 2.479

6.  The origin and evolution of mutations in acute myeloid leukemia.

Authors:  John S Welch; Timothy J Ley; Daniel C Link; Christopher A Miller; David E Larson; Daniel C Koboldt; Lukas D Wartman; Tamara L Lamprecht; Fulu Liu; Jun Xia; Cyriac Kandoth; Robert S Fulton; Michael D McLellan; David J Dooling; John W Wallis; Ken Chen; Christopher C Harris; Heather K Schmidt; Joelle M Kalicki-Veizer; Charles Lu; Qunyuan Zhang; Ling Lin; Michelle D O'Laughlin; Joshua F McMichael; Kim D Delehaunty; Lucinda A Fulton; Vincent J Magrini; Sean D McGrath; Ryan T Demeter; Tammi L Vickery; Jasreet Hundal; Lisa L Cook; Gary W Swift; Jerry P Reed; Patricia A Alldredge; Todd N Wylie; Jason R Walker; Mark A Watson; Sharon E Heath; William D Shannon; Nobish Varghese; Rakesh Nagarajan; Jacqueline E Payton; Jack D Baty; Shashikant Kulkarni; Jeffery M Klco; Michael H Tomasson; Peter Westervelt; Matthew J Walter; Timothy A Graubert; John F DiPersio; Li Ding; Elaine R Mardis; Richard K Wilson
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

7.  Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer.

Authors:  Sei Naito; Vladimir Bilim; Kaori Yuuki; Andrey Ugolkov; Teiichi Motoyama; Akira Nagaoka; Tomoyuki Kato; Yoshihiko Tomita
Journal:  Clin Cancer Res       Date:  2010-10-01       Impact factor: 12.531

8.  Increased expression of HMGB1 is associated with poor prognosis in human bladder cancer.

Authors:  Guo-Liang Yang; Lian-Hua Zhang; Juan-Jie Bo; Xiao-Jiao Huo; Hai-Ge Chen; Ming Cao; Dong-Ming Liu; Yi-Ran Huang
Journal:  J Surg Oncol       Date:  2012-01-11       Impact factor: 3.454

Review 9.  Genetic alterations in urothelial bladder carcinoma: an updated review.

Authors:  Paulette Mhawech-Fauceglia; Richard T Cheney; Juerg Schwaller
Journal:  Cancer       Date:  2006-03-15       Impact factor: 6.860

10.  Expression of parvin-beta is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract.

Authors:  C-F Wu; K-F Ng; C-S Chen; P-L Chang; C-K Chuang; W-H Weng; S-K Liao; S-T Pang
Journal:  Br J Cancer       Date:  2010-08-24       Impact factor: 7.640

View more
  10 in total

1.  Molecular Basis for Cohesin Acetylation by Establishment of Sister Chromatid Cohesion N-Acetyltransferase ESCO1.

Authors:  Yadilette Rivera-Colón; Andrew Maguire; Glen P Liszczak; Adam S Olia; Ronen Marmorstein
Journal:  J Biol Chem       Date:  2016-11-01       Impact factor: 5.157

2.  The cohesion establishment factor Esco1 acetylates α-tubulin to ensure proper spindle assembly in oocyte meiosis.

Authors:  Yajuan Lu; Sen Li; Zhaokang Cui; Xiaoxin Dai; Mianqun Zhang; Yilong Miao; Changyin Zhou; Xianghong Ou; Bo Xiong
Journal:  Nucleic Acids Res       Date:  2018-03-16       Impact factor: 16.971

3.  Proteomic profiling of human intraschisis cavity fluid.

Authors:  Dhandayuthapani Sudha; Mahdokht Kohansal-Nodehi; Purnima Kovuri; Srikanth Srinivas Manda; Srividya Neriyanuri; Lingam Gopal; Pramod Bhende; Subbulakshmi Chidambaram; Jayamuruga Pandian Arunachalam
Journal:  Clin Proteomics       Date:  2017-04-24       Impact factor: 3.988

4.  ESCO2 inhibits tumor metastasis via transcriptionally repressing MMP2 in colorectal cancer.

Authors:  Xiong-Bo Guo; Bin Huang; Ying-Hua Pan; Shu-Guang Su; Yan Li
Journal:  Cancer Manag Res       Date:  2018-11-22       Impact factor: 3.989

5.  ESCO1/2's roles in chromosome structure and interphase chromatin organization.

Authors:  Ryotaro Kawasumi; Takuya Abe; Hiroshi Arakawa; Massimiliano Garre; Kouji Hirota; Dana Branzei
Journal:  Genes Dev       Date:  2017-12-01       Impact factor: 11.361

6.  Actein induces autophagy and apoptosis in human bladder cancer by potentiating ROS/JNK and inhibiting AKT pathways.

Authors:  Lu Ji; Bing Zhong; Xi Jiang; Fei Mao; Gang Liu; Bin Song; Cheng-Yuan Wang; Yong Jiao; Jiang-Ping Wang; Zhi-Bin Xu; Xing Li; Bo Zhan
Journal:  Oncotarget       Date:  2017-11-01

7.  Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.

Authors:  Longsheng Wang; Shaojun Chen; Ziwei Zhang; Junfeng Zhang; Shiyu Mao; Jiayi Zheng; Yang Xuan; Mengnan Liu; Keke Cai; Wentao Zhang; Yadong Guo; Wei Zhai; Xudong Yao
Journal:  BMC Cancer       Date:  2018-11-20       Impact factor: 4.430

8.  Establishment of cohesion 1 homolog 2 facilitates cell aggressive behaviors and induces poor prognosis in renal cell carcinoma.

Authors:  Qiu-Li Wang; Ling Liu
Journal:  J Clin Lab Anal       Date:  2020-01-15       Impact factor: 2.352

9.  Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma.

Authors:  Ravinnipa Chanakankun; Tanakorn Proungvitaya; Daraporn Chua-On; Temduang Limpaiboon; Sittiruk Roytrakul; Apinya Jusakul; Attapol Titapun; Apiwat Jarearnrat; Siriporn Proungvitaya
Journal:  Oncol Lett       Date:  2019-11-29       Impact factor: 2.967

10.  Genes Associated With Chromatin Modification Within the Swine Placenta Are Differentially Expressed Due to Factors Associated With Season.

Authors:  Lea A Rempel; John J Parrish; Jeremy R Miles
Journal:  Front Genet       Date:  2020-09-23       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.